First Time Loading...

Cencora Inc
NYSE:COR

Watchlist Manager
Cencora Inc Logo
Cencora Inc
NYSE:COR
Watchlist
Price: 239.13 USD 0.77% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Cencora, Inc. sources and distributes pharmaceutical products. [ Read More ]

The intrinsic value of one COR stock under the Base Case scenario is 408.15 USD. Compared to the current market price of 239.13 USD, Cencora Inc is Undervalued by 41%.

Key Points:
COR Intrinsic Value
Base Case
408.15 USD
Undervaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Cencora Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling COR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Cencora Inc

Provide an overview of the primary business activities
of Cencora Inc.

What unique competitive advantages
does Cencora Inc hold over its rivals?

What risks and challenges
does Cencora Inc face in the near future?

Has there been any significant insider trading activity
in Cencora Inc recently?

Summarize the latest earnings call
of Cencora Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cencora Inc.

Provide P/S
for Cencora Inc.

Provide P/E
for Cencora Inc.

Provide P/OCF
for Cencora Inc.

Provide P/FCFE
for Cencora Inc.

Provide P/B
for Cencora Inc.

Provide EV/S
for Cencora Inc.

Provide EV/GP
for Cencora Inc.

Provide EV/EBITDA
for Cencora Inc.

Provide EV/EBIT
for Cencora Inc.

Provide EV/OCF
for Cencora Inc.

Provide EV/FCFF
for Cencora Inc.

Provide EV/IC
for Cencora Inc.

Show me price targets
for Cencora Inc made by professional analysts.

What are the Revenue projections
for Cencora Inc?

How accurate were the past Revenue estimates
for Cencora Inc?

What are the Net Income projections
for Cencora Inc?

How accurate were the past Net Income estimates
for Cencora Inc?

What are the EPS projections
for Cencora Inc?

How accurate were the past EPS estimates
for Cencora Inc?

What are the EBIT projections
for Cencora Inc?

How accurate were the past EBIT estimates
for Cencora Inc?

Compare the revenue forecasts
for Cencora Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cencora Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cencora Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cencora Inc compared to its peers.

Compare the P/E ratios
of Cencora Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Cencora Inc with its peers.

Analyze the financial leverage
of Cencora Inc compared to its main competitors.

Show all profitability ratios
for Cencora Inc.

Provide ROE
for Cencora Inc.

Provide ROA
for Cencora Inc.

Provide ROIC
for Cencora Inc.

Provide ROCE
for Cencora Inc.

Provide Gross Margin
for Cencora Inc.

Provide Operating Margin
for Cencora Inc.

Provide Net Margin
for Cencora Inc.

Provide FCF Margin
for Cencora Inc.

Show all solvency ratios
for Cencora Inc.

Provide D/E Ratio
for Cencora Inc.

Provide D/A Ratio
for Cencora Inc.

Provide Interest Coverage Ratio
for Cencora Inc.

Provide Altman Z-Score Ratio
for Cencora Inc.

Provide Quick Ratio
for Cencora Inc.

Provide Current Ratio
for Cencora Inc.

Provide Cash Ratio
for Cencora Inc.

What is the historical Revenue growth
over the last 5 years for Cencora Inc?

What is the historical Net Income growth
over the last 5 years for Cencora Inc?

What is the current Free Cash Flow
of Cencora Inc?

Financials

Balance Sheet Decomposition
Cencora Inc

Current Assets 44.9B
Cash & Short-Term Investments 2.9B
Receivables 22.8B
Other Current Assets 19.1B
Non-Current Assets 19.8B
PP&E 2.1B
Intangibles 14B
Other Non-Current Assets 3.7B
Current Liabilities 50.8B
Accounts Payable 47.7B
Accrued Liabilities 2.4B
Other Current Liabilities 592.8m
Non-Current Liabilities 13B
Long-Term Debt 4.2B
Other Non-Current Liabilities 8.8B
Efficiency

Earnings Waterfall
Cencora Inc

Revenue
271.6B USD
Cost of Revenue
-262.4B USD
Gross Profit
9.1B USD
Operating Expenses
-6.5B USD
Operating Income
2.7B USD
Other Expenses
-797.9m USD
Net Income
1.9B USD

Free Cash Flow Analysis
Cencora Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

COR Profitability Score
Profitability Due Diligence

Cencora Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
ROE is Increasing
Positive 3-Year Average ROIC
60/100
Profitability
Score

Cencora Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

COR Solvency Score
Solvency Due Diligence

Cencora Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Positive Net Debt
Long-Term Solvency
63/100
Solvency
Score

Cencora Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

COR Price Targets Summary
Cencora Inc

Wall Street analysts forecast COR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COR is 259.59 USD with a low forecast of 226.24 USD and a high forecast of 288.75 USD.

Lowest
Price Target
226.24 USD
5% Downside
Average
Price Target
259.59 USD
9% Upside
Highest
Price Target
288.75 USD
21% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

COR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

COR Price
Cencora Inc

1M 1M
-1%
6M 6M
+27%
1Y 1Y
+45%
3Y 3Y
+105%
5Y 5Y
+261%
10Y 10Y
+328%
Annual Price Range
239.13
52w Low
164.159
52w High
245.8
Price Metrics
Average Annual Return 25.47%
Standard Deviation of Annual Returns 10.23%
Max Drawdown -5%
Shares Statistics
Market Capitalization 47.7B USD
Shares Outstanding 199 461 864
Percentage of Shares Shorted 3.61%

COR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Cencora Inc Logo
Cencora Inc

Country

United States of America

Industry

Health Care

Market Cap

47.7B USD

Dividend Yield

1.04%

Description

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Contact

PENNSYLVANIA
Conshohocken
1 West First Avenue
+16107277000
https://www.cencora.com/

IPO

1996-05-28

Employees

39 000

Officers

Chairman, President & CEO
Mr. Steven H. Collis
Executive VP & CFO
Mr. James F. Cleary Jr.
Executive VP & COO
Dr. Robert P. Mauch Ph.D., PharmD
Executive VP and Chief Communications & Administration Officer
Ms. Gina K. Clark
Executive VP & Chief Legal Officer
Ms. Elizabeth S. Campbell
Senior VP, Chief Accounting Officer & Corporate Controller
Mr. Lazarus Krikorian
Show More
Senior Vice President of Investor Relations
Bennett S. Murphy
Senior VP & Chief Compliance Officer
Ms. Jennifer E. Dubas
Executive VP & Chief Human Resources Officer
Ms. Silvana Battaglia
Executive VP & Chief Strategy Officer
Ms. Leslie E. Donato
Show Less

See Also

Discover More
What is the Intrinsic Value of one COR stock?

The intrinsic value of one COR stock under the Base Case scenario is 408.15 USD.

Is COR stock undervalued or overvalued?

Compared to the current market price of 239.13 USD, Cencora Inc is Undervalued by 41%.